Granulocyte-Macrophage Colony-Stimulating Factor Regulates Effector Differentiation of Invariant Natural Killer T Cells during Thymic Ontogeny

Immunity

Volumn 25, Issue 3, 2006, Pages 487-497

  Bezbradica, Jelena S ^a   Gordy, Laura E ^a   Stanic, Aleksandar K ^a   Dragovic, Srdjan ^a   Hill, Timothy ^a   Hawiger, Jacek ^a   Unutmaz, Derya ^a   Van Kaer, Luc ^a   Joyce, Sebastian ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CELLIMMUNO; DEVBIO

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL MATURATION; CELL MEMBRANE; CONTROLLED STUDY; CYTOKINE RELEASE; LYMPHOCYTE DIFFERENTIATION; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SECRETORY VESICLE; SPLEEN; THYMUS;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; CYTOKINES; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; KILLER CELLS, NATURAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-KAPPA B; RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR; T-LYMPHOCYTE SUBSETS; THYMUS GLAND;

EID: 33748444060     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2006.06.017     Document Type: Article

References (56)

1. Benlagha K., Kyin T., Beavis A., Teyton L., and Bendelac A. A thymic precursor to the NK T cell lineage. Science 296 (2002) 553-555
2. Benlagha K., Wei D.G., Veiga J., Teyton L., and Bendelac A. Characterization of the early stages of thymic NKT cell development. J. Exp. Med. 202 (2005) 485-492
3. + stage of thymic ontogeny. Proc. Natl. Acad. Sci. USA 102 (2005) 5114-5119
4. Bezbradica J.S., Stanic A.K., Matsuki N., Bour-Jordan H., Bluestone J.A., Thomas J.W., Unutmaz D., Van Kaer L., and Joyce S. Distinct roles of dendritic cells and B cells in Va14Ja18 natural T cell activation in vivo. J. Immunol. 174 (2005) 4696-4705
5. Bezbradica J.S., Stanic A.K., and Joyce S. Characterization and functional analysis of mouse invariant natural T (iNKT) cells. Curr. Protocols Immunol. (2006) 14.13.11-14.13.27
6. Bossi G., and Griffiths G.M. CTL secretory lysosomes: biogenesis and secretion of a harmful organelle. Semin. Immunol. 17 (2005) 87-94
7. Brigl M., Bry L., Kent S.C., Gumperz J.E., and Brenner M.B. Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat. Immunol. 4 (2003) 1230-1237
8. Burdin N., Brossay L., and Kronenberg M. Immunization with α-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis. Eur. J. Immunol. 29 (1999) 2014-2025
9. Burgoyne R.D., and Morgan A. Secretory granule exocytosis. Physiol. Rev. 83 (2003) 581-632
10. Carnaud C., Lee D., Donnars O., Park S.H., Beavis A., Koezuka Y., and Bendelac A. Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J. Immunol. 163 (1999) 4647-4650
11. Chung B., Aoukaty A., Dutz J., Terhorst C., and Tan R. Signaling lymphocytic activation molecule-associated protein controls NKT cell functions. J. Immunol. 174 (2005) 3153-3157
12. Crowe N.Y., Uldrich A.P., Kyparissoudis K., Hammond K.J., Hayakawa Y., Sidobre S., Keating R., Kronenberg M., Smyth M.J., and Godfrey D.I. Glycolipid antigen drives rapid expansion and sustained cytokine production by NK T cells. J. Immunol. 171 (2003) 4020-4027
13. Cui J., Shin T., Kawano T., Sato H., Kondo E., Toura I., Kaneko Y., Koseki H., Kanno M., and Taniguchi M. Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors. Science 278 (1997) 1623-1626
14. Dranoff G., Crawford A.D., Sadelain M., Ream B., Rashid A., Bronson R.T., Dickersin G.R., Bachurski C.J., Mark E.L., Whitsett J.A., et al. Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science 264 (1994) 713-716
15. Eberl G., Lowin-Kropf B., and MacDonald H.R. NKT cell development is selectively impaired in Fyn-deficient mice. J. Immunol. 163 (1999) 4091-4094
16. Ebner K., Bandion A., Binder B.R., de Martin R., and Schmid J.A. GMCSF activates NF-κB via direct interaction of the GMCSF receptor with IκB kinase β. Blood 102 (2003) 192-199
17. Egawa T., Eberl G., Taniuchi I., Benlagha K., Geissmann F., Hennighausen L., Bendelac A., and Littman D.R. Genetic evidence supporting selection of the Vα14i NKT cell lineage from double-positive thymocyte precursors. Immunity 22 (2005) 705-716
18. Enzler T., and Dranoff G. Granulocyte-macrophage colony-stimulating factor. In: Thomson A.W., and Lotze M.T. (Eds). The Cytokine Handbook (2003), Academic Press, San Diego 503-524
19. Fujii S., Shimizu K., Smith C., Bonifaz L., and Steinman R.M. Activation of natural killer T cells by α-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein. J. Exp. Med. 198 (2003) 267-279
20. Gadue P., and Stein P.L. NK T cell precursors exhibit differential cytokine regulation and require Itk for efficient maturation. J. Immunol. 169 (2002) 2397-2406
21. Gadue P., Morton N., and Stein P.L. The Src family tyrosine kinase Fyn regulates natural killer T cell development. J. Exp. Med. 190 (1999) 1189-1196
22. Gapin L., Matsuda J.L., Surh C.D., and Kronenberg M. NKT cells derive from double-positive thymocytes that are positively selected by CD1d. Nat. Immunol. 2 (2001) 971-978
23. + T cell responses to soluble antigen in vivo through direct interaction with dendritic cells. J. Immunol. 171 (2003) 5140-5147
24. Intlekofer A.M., Takemoto N., Wherry E.J., Longworth S.A., Northrup J.T., Palanivel V.R., Mullen A.C., Gasink C.R., Kaech S.M., Miller J.D., et al. Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin. Nat. Immunol. 6 (2005) 1236-1244
25. Kinjo Y., Wu D., Kim G., Xing G.W., Poles M.A., Ho D.D., Tsuji M., Kawahara K., Wong C.H., and Kronenberg M. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 434 (2005) 520-525
26. Lacorazza H.D., Miyazaki Y., Di Cristofano A., Deblasio A., Hedvat C., Zhang J., Cordon-Cardo C., Mao S., Pandolfi P.P., and Nimer S.D. The ETS protein MEF plays a critical role in perforin gene expression and the development of natural killer and NK-T cells. Immunity 17 (2002) 437-449
27. Matsuda J.L., Gapin L., Baron J.L., Sidobre S., Stetson D.B., Mohrs M., Locksley R.M., and Kronenberg M. Mouse Vα14i natural killer T cells are resistant to cytokine polarization in vivo. Proc. Natl. Acad. Sci. USA 100 (2003) 8395-8400
28. Mattner J., Debord K.L., Ismail N., Goff R.D., Cantu III C., Zhou D., Saint-Mezard P., Wang V., Gao Y., Yin N., et al. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434 (2005) 525-529
29. Mendiratta S.K., Martin W.D., Hong S., Boesteanu A., Joyce S., and Van Kaer L. CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. Immunity 6 (1997) 469-477
30. + T cells. J. Immunol. 173 (2004) 726-730
31. Murray R.Z., Kay J.G., Sangermani D.G., and Stow J.L. A role for the phagosome in cytokine secretion. Science 310 (2005) 1492-1495
32. Pasquier B., Yin L., Fondaneche M.C., Relouzat F., Bloch-Queyrat C., Lambert N., Fischer A., de Saint-Basile G., and Latour S. Defective NKT cell development in mice and humans lacking the adapter SAP, the X-linked lymphoproliferative syndrome gene product. J. Exp. Med. 201 (2005) 695-701
33. Pearce E.L., Mullen A.C., Martins G.A., Krawczyk C.M., Hutchins A.S., Zediak V.P., Banica M., DiCioccio C.B., Gross D.A., Mao C.A., et al. Control of effector CD8+ T cell function by the transcription factor Eomesodermin. Science 302 (2003) 1041-1043
34. + CD1d-dependent precursor stage. J. Exp. Med. 195 (2002) 835-844
35. Peters P.J., Borst J., Oorschot V., Fukuda M., Krahenbuhl O., Tschopp J., Slot J.W., and Geuze H.J. Cytotoxic T lymphocyte granules are secretory lysosomes, containing both perforin and granzymes. J. Exp. Med. 173 (1991) 1099-1109
36. Sato H., Nakayama T., Tanaka Y., Yamashita M., Shibata Y., Kondo E., Saito Y., and Taniguchi M. Induction of differentiation of pre-NKT cells to mature Vα14 NKT cells by granulocyte/macrophage colony-stimulating factor. Proc. Natl. Acad. Sci. USA 96 (1999) 7439-7444
37. + regulatory and natural killer-like T cells on signals leading to NF-κB activation. Proc. Natl. Acad. Sci. USA 101 (2004) 4566-4571
38. Schmieg J., Yang G., Franck R.W., Van Rooijen N., and Tsuji M. Glycolipid presentation to natural killer T cells differs in an organ-dependent fashion. Proc. Natl. Acad. Sci. USA 102 (2005) 1127-1132
39. Silk J.D., Hermans I.F., Gileadi U., Chong T.W., Shepherd D., Salio M., Mathew B., Schmidt R.R., Lunt S.J., Williams K.J., et al. Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell-mediated immunotherapy. J. Clin. Invest. 114 (2004) 1800-1811
40. Singh N., Hong S., Scherer D.C., Serizawa I., Burdin N., Kronenberg M., Koezuka Y., and Van Kaer L. Activation of NK T cells by CD1d and α-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype. J. Immunol. 163 (1999) 2373-2377
41. Sivakumar V., Hammond K.J., Howells N., Pfeffer K., and Weih F. Differential requirement for Rel/nuclear factor kappa B family members in natural killer T cell development. J. Exp. Med. 197 (2003) 1613-1621
42. + T cells and natural killer cells is essential for the antimetastatic effect of α-galactosylceramide. Blood 99 (2002) 1259-1266
43. Sriram V., Du W., Gervay-Hague J., and Brutkiewicz R.R. Cell wall glycosphingolipids of Sphingomonas paucimobilis are CD1d-specific ligands for NKT cells. Eur. J. Immunol. 35 (2005) 1692-1701
44. Stanic A.K., Bezbradica J.S., Park J.J., Matsuki N., Mora A.L., Van Kaer L., Boothby M.R., and Joyce S. NF-κB controls cell fate specification, survival, and molecular differentiation of immunoregulatory natural T lymphocytes. J. Immunol. 172 (2004) 2265-2273
45. Stanic A.K., Bezbradica J.S., Park J.J., Van Kaer L., Boothby M.R., and Joyce S. The ontogeny and function of Va14Ja18 natural T lymphocytes require signal processing by protein kinase Cθ and NF-κB. J. Immunol. 172 (2004) 4667-4671
46. Stanley E., Lieschke G.J., Grail D., Metcalf D., Hodgson G., Gall J.A., Maher D.W., Cebon J., Sinickas V., and Dunn A.R. Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc. Natl. Acad. Sci. USA 91 (1994) 5592-5596
47. Stetson D.B., Mohrs M., Reinhardt R.L., Baron J.L., Wang Z.E., Gapin L., Kronenberg M., and Locksley R.M. Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function. J. Exp. Med. 198 (2003) 1069-1076
48. Thomas R.S., Tymms M.J., McKinlay L.H., Shannon M.F., Seth A., and Kola I. ETS1, NFκB and AP1 synergistically transactivate the human GM-CSF promoter. Oncogene 14 (1997) 2845-2855
49. Townsend M.J., Weinmann A.S., Matsuda J.L., Salomon R., Farnham P.J., Biron C.A., Gapin L., and Glimcher L.H. T-bet regulates the terminal maturation and homeostasis of NK and Vα14i NKT cells. Immunity 20 (2004) 477-494
50. Van Kaer L. α-Galactosylceramide therapy for autoimmune diseases: prospects and obstacles. Nat. Rev. Immunol. 5 (2005) 31-42
51. Wada H., Noguchi Y., Marino M.W., Dunn A.R., and Old L.J. T cell functions in granulocyte/macrophage colony-stimulating factor deficient mice. Proc. Natl. Acad. Sci. USA 94 (1997) 12557-12561
52. Walunas T.L., Wang B., Wang C.R., and Leiden J.M. The Ets1 transcription factor is required for the development of NK T cells in mice. J. Immunol. 164 (2000) 2857-2860
53. Wilson M.T., Johansson C., Olivares-Villagomez D., Singh A.K., Stanic A.K., Wang C.R., Joyce S., Wick M.J., and Van Kaer L. The response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion. Proc. Natl. Acad. Sci. USA 100 (2003) 10913-10918
54. pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. J. Exp. Med. 179 (1994) 1285-1295
55. Yoshimura Y., Yadav R., Christianson G.J., Ajayi W.U., Roopenian D.C., and Joyce S. Duration of alloantigen presentation and avidity of T cell antigen recognition correlate with immunodominance of CTL response to minor histocompatibility antigens. J. Immunol. 172 (2004) 6666-6674
56. Zhou D., Mattner J., Cantu III C., Schrantz N., Yin N., Gao Y., Sagiv Y., Hudspeth K., Wu Y.P., Yamashita T., et al. Lysosomal glycosphingolipid recognition by NKT cells. Science 306 (2004) 1786-1789